GlassScriptPhysician profile
Piyush N Joshi
NPI 1083697817
$28,311.03
in general payments reported to CMS, 2019-2025
73 companies · $5,295 in 2025
The $5,295 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,286 · 2020: $985 · 2021: $3,267 · 2022: $8,027 · 2023: $3,452 · 2024: $5,999 · 2025: $5,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $2,690 · Education: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,746.41 |
| Travel and Lodging | $2,690.15 |
| Education | $308.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $5,872.68 | 2022-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $2,497.21 | 2019-2025 | Moses 550 Dfl, Lithovue, Ams 700 |
| Janssen Biotech, INC. | $1,949.43 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Astrazeneca Pharmaceuticals LP | $1,383.35 | 2020-2025 | Lynparza, Calquence, Enhertu |
| E.R. Squibb & Sons, L.L.C. | $1,270.16 | 2021-2025 | Opdivo, Abecma, Augtyro |
| Astellas Pharma US INC | $1,095.08 | 2019-2025 | Xtandi |
| Axonics, INC. | $868.53 | 2022-2023 | Axonics |
| Regeneron Healthcare Solutions, INC. | $864.66 | 2021-2025 | Libtayo |
| Coloplast Corp | $819.38 | 2022-2025 | |
| Pfizer INC. | $797.65 | 2019-2025 | |
| Incyte Corporation | $705.89 | 2021-2024 | Jakafi, Monjuvi |
| Bayer Healthcare Pharmaceuticals INC. | $543.00 | 2020-2025 | |
| Glaxosmithkline, LLC. | $521.41 | 2022-2025 | Ojjaara, Zejula |
| Genentech USA, INC. | $519.96 | 2021-2023 | Lunsumio |
| Daiichi Sankyo INC. | $498.38 | 2022-2025 | Enhertu |
Show all 73 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Piyush Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.